Latest Insider Transactions at Anavex Life Sciences Corp. (AVXL)
This section provides a real-time view of insider transactions for Anavex Life Sciences Corp. (AVXL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANAVEX LIFE SCIENCES CORP. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANAVEX LIFE SCIENCES CORP.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2024
|
Peter D.O. Donhauser Director |
BUY
Open market or private purchase
|
Direct |
2,835
+36.18%
|
$8,505
$3.64 P/Share
|
|
May 15
2024
|
Steffen Thomas Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$20,000
$4.52 P/Share
|
|
Mar 28
2024
|
Christopher U Missling President and CEO |
SELL
Open market or private sale
|
Direct |
73,380
-5.54%
|
$366,900
$5.11 P/Share
|
|
Mar 28
2024
|
Christopher U Missling President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
73,380
+5.25%
|
$73,380
$1.32 P/Share
|
|
Jun 29
2023
|
Christopher U Missling President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
232,000
+15.65%
|
$232,000
$1.6 P/Share
|
|
Jun 28
2023
|
Christopher U Missling President and CEO |
SELL
Open market or private sale
|
Direct |
268,000
-20.84%
|
$1,876,000
$7.98 P/Share
|
|
Jun 28
2023
|
Christopher U Missling President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
268,000
+17.24%
|
$268,000
$1.6 P/Share
|
|
May 25
2022
|
Athanasios Skarpelos Director |
SELL
Open market or private sale
|
Direct |
50,000
-3.69%
|
$450,000
$9.06 P/Share
|
|
May 25
2022
|
Athanasios Skarpelos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+3.56%
|
$0
$0.92 P/Share
|
|
Jun 29
2021
|
Sandra Boenisch PFO & Treasurer |
SELL
Open market or private sale
|
Direct |
166,696
-87.89%
|
$4,334,096
$26.53 P/Share
|
|
Jun 29
2021
|
Sandra Boenisch PFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
166,696
+30.22%
|
$666,784
$4.96 P/Share
|
|
Jun 29
2021
|
Christopher U Missling President and CEO |
SELL
Open market or private sale
|
Direct |
51,620
-4.83%
|
$1,342,120
$26.0 P/Share
|
|
Jun 29
2021
|
Christopher U Missling President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
51,620
+4.6%
|
$51,620
$1.32 P/Share
|
|
May 21
2021
|
Elliot Favus Director |
SELL
Open market or private sale
|
Direct |
145,000
-100.0%
|
$1,595,000
$11.7 P/Share
|
|
May 21
2021
|
Elliot Favus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
145,000
+15.0%
|
$580,000
$4.12 P/Share
|
|
May 17
2021
|
Peter D.O. Donhauser Director |
BUY
Open market or private purchase
|
Direct |
1,000
+31.6%
|
$10,000
$10.93 P/Share
|
|
Feb 24
2021
|
Elliot Favus Director |
SELL
Open market or private sale
|
Direct |
145,500
-100.0%
|
$1,746,000
$12.66 P/Share
|
|
Feb 24
2021
|
Elliot Favus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
145,500
+45.55%
|
$291,000
$2.93 P/Share
|
|
Feb 19
2021
|
Peter D.O. Donhauser Director |
BUY
Open market or private purchase
|
Direct |
1,165
+31.2%
|
$13,980
$12.8 P/Share
|